WBR0247: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
m (refreshing WBR questions) |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{Rim}} | |QuestionAuthor= {{Rim}} (Reviewed by William J Gibson and {{YD}}) | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
Line 8: | Line 8: | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|MainCategory=Pathology | |||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
Line 20: | Line 21: | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|SubCategory=Gastrointestinal | |SubCategory=Gastrointestinal | ||
|Prompt=A 45 year old | |Prompt=A 45-year-old man presents to the physician's office for an annual check-up. His father was diagnosed with colon cancer at the age of 55, and the physician now recommends that the patient undergoes a screening colonoscopy. The physician then explains that the majority of colon cancer cases are due to sporadic development, but familial forms are also present. A mutation in which gene is most likely associated with familial colon cancer? | ||
|Explanation=Familial adenomatosis polyposis (FAP) is | |Explanation=[[Familial adenomatosis polyposis]] (FAP) is an autosomal dominant genetic disease caused by a mutation in the ''APC'' gene on chromosome 5q. FAP is often characterized by the development of hundreds of polyps that ultimately progress to colon cancer in affected individuals. The genetic and clinical evolution of colon cancer proceeds through a well characterized adenoma-to-carcinoma” sequence. In normal individuals, two functioning copies of the ''APC'' gene exist in all cells. To bi-allelically inactivate the ''APC'' gene, both copies must be mutated or deleted. However, in individuals with FAP, one copy of the gene has already been inactivated since birth, thereby shortening the somatic process of bi-allelic inactivation to one "hit". Loss-of-function of the ''APC'' gene leads to hyperactivation of the beta-catenin pathway, a crucial signaling pathway that governs growth control in the colonic epithelium. Therefore, loss of ''APC'' leads to the formation of small polyps. However, inactivation of ''APC'' alone is insufficient to cause carcinoma. Secondary oncogenic genetic alterations must occur, the most common of which is mutation of a single amino acid in the ''KRAS'' gene. ''KRAS'' mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. Further loss of the tumor suppressor genes ''TP53'' and ''SMAD4'' lead to the transformation of the tumor from an adenoma into a carcinoma. The cooperation of the ''APC'', ''KRAS'', and ''TP53'' genes in colon cancer is the best documented instance of "oncogene cooperation" in cancer biology. | ||
|AnswerA=''C-KIT'' | |||
|AnswerAExp=''[[C-KIT]]'' oncogene is associated with gastrointestinal stromal tumors ([[GIST]]). | |||
|AnswerB=''RET'' | |||
|AnswerBExp=The ''[[Ret gene|RET oncogene]]'' is associated with [[multiple endocrine neoplasia]] (MEN) syndromes 2A and 2B | |||
|AnswerA=C- | |AnswerC=''BRAF'' | ||
|AnswerAExp=[[C- | |AnswerCExp=The ''BRAF'' oncogene is associated with melanoma. | ||
|AnswerB= | |AnswerD=''KRAS'' | ||
|AnswerBExp=[[Ret gene| | |AnswerDExp=The ''[[KRAS]]'' oncogene is associated with colorectal cancer. | ||
|AnswerC= | |AnswerE=''C-MYC'' | ||
|AnswerCExp= | |AnswerEExp=The ''[[C-MYC]]'' oncogene is associated with [[Burkitt's lymphoma]]. | ||
|AnswerD= | |EducationalObjectives=Mutations in [[Ras|''KRAS'']] oncogene are implicated in the tumorigenesis of [[colon cancer]]. ''KRAS'' mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. | ||
|AnswerDExp=[[ | |References=Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67.<br> | ||
|AnswerE=C- | First Aid 2014 page 359 <br> | ||
|AnswerEExp=C- | |||
|RightAnswer=D | |RightAnswer=D | ||
|Approved= | |WBRKeyword=Cancer, Colon cancer, Polyp, FAP, Familial adenomatous polyposis, CRC, Colorectal cancer | ||
|Approved=Yes | |||
}} | }} |
Latest revision as of 23:54, 27 October 2020
Author | [[PageAuthor::Rim Halaby, M.D. [1] (Reviewed by William J Gibson and Yazan Daaboul, M.D.)]] |
---|---|
Exam Type | ExamType::USMLE Step 1 |
Main Category | MainCategory::Pathology |
Sub Category | SubCategory::Gastrointestinal |
Prompt | [[Prompt::A 45-year-old man presents to the physician's office for an annual check-up. His father was diagnosed with colon cancer at the age of 55, and the physician now recommends that the patient undergoes a screening colonoscopy. The physician then explains that the majority of colon cancer cases are due to sporadic development, but familial forms are also present. A mutation in which gene is most likely associated with familial colon cancer?]] |
Answer A | AnswerA::''C-KIT'' |
Answer A Explanation | [[AnswerAExp::C-KIT oncogene is associated with gastrointestinal stromal tumors (GIST).]] |
Answer B | AnswerB::''RET'' |
Answer B Explanation | [[AnswerBExp::The RET oncogene is associated with multiple endocrine neoplasia (MEN) syndromes 2A and 2B]] |
Answer C | AnswerC::''BRAF'' |
Answer C Explanation | AnswerCExp::The ''BRAF'' oncogene is associated with melanoma. |
Answer D | AnswerD::''KRAS'' |
Answer D Explanation | [[AnswerDExp::The KRAS oncogene is associated with colorectal cancer.]] |
Answer E | AnswerE::''C-MYC'' |
Answer E Explanation | [[AnswerEExp::The C-MYC oncogene is associated with Burkitt's lymphoma.]] |
Right Answer | RightAnswer::D |
Explanation | [[Explanation::Familial adenomatosis polyposis (FAP) is an autosomal dominant genetic disease caused by a mutation in the APC gene on chromosome 5q. FAP is often characterized by the development of hundreds of polyps that ultimately progress to colon cancer in affected individuals. The genetic and clinical evolution of colon cancer proceeds through a well characterized adenoma-to-carcinoma” sequence. In normal individuals, two functioning copies of the APC gene exist in all cells. To bi-allelically inactivate the APC gene, both copies must be mutated or deleted. However, in individuals with FAP, one copy of the gene has already been inactivated since birth, thereby shortening the somatic process of bi-allelic inactivation to one "hit". Loss-of-function of the APC gene leads to hyperactivation of the beta-catenin pathway, a crucial signaling pathway that governs growth control in the colonic epithelium. Therefore, loss of APC leads to the formation of small polyps. However, inactivation of APC alone is insufficient to cause carcinoma. Secondary oncogenic genetic alterations must occur, the most common of which is mutation of a single amino acid in the KRAS gene. KRAS mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. Further loss of the tumor suppressor genes TP53 and SMAD4 lead to the transformation of the tumor from an adenoma into a carcinoma. The cooperation of the APC, KRAS, and TP53 genes in colon cancer is the best documented instance of "oncogene cooperation" in cancer biology. Educational Objective: Mutations in KRAS oncogene are implicated in the tumorigenesis of colon cancer. KRAS mutation leads to uncontrolled MAP kinase signaling of the colonic epithelium. |
Approved | Approved::Yes |
Keyword | WBRKeyword::Cancer, WBRKeyword::Colon cancer, WBRKeyword::Polyp, WBRKeyword::FAP, WBRKeyword::Familial adenomatous polyposis, WBRKeyword::CRC, WBRKeyword::Colorectal cancer |
Linked Question | Linked:: |
Order in Linked Questions | LinkedOrder:: |